Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00164554
Other study ID # CDC-NCBDDD-3813
Secondary ID U84/CCU020163-02
Status Completed
Phase Phase 1/Phase 2
First received September 12, 2005
Last updated April 25, 2008
Start date October 2001
Est. completion date June 2005

Study information

Verified date September 2005
Source Centers for Disease Control and Prevention
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Children will receive comprehensive evaluations through the UOHSC ABC program The assessment for the child will include: medical issues (including medication), dysmorphic examination, intellectual assessment, academic achievement, language, and motor skills. This program will provide appropriate non-study services and referrals. Eligible families will be randomly assigned to treatment group or control group. Treatment group will receive Parent Child Interaction Therapy (PCIT). The Control group will receive standard referrals and services through the ABC program and the parent education/advocacy component of the project.


Description:

PCIT has been adapted by the applicant for group administration. The intervention will consist of 90-minute sessions of PCIT once a week for 14 weeks. During PCIT sessions parents and children will participate in activities that promote interactions. A behavior specialist who will be observing through a two-way mirror assists parents in development of appropriate behaviors and interaction techniques. Parents will be prompted by use of in-ear devices (i.e., bug in the ear). This intervention has been shown to be effective in other populations. For each family, individualized goals for parent-child interactions will be set and reviewed each session. Homework assignments also will be given.

Parent Component: Three 90-minute sessions conducted in a group format. Topics will include: FAS/ARND education, impact of FAS/ARND on families, specific development of a child with FAS/ARND, and FAS/ARND social skills and deficits.

Evaluation Plan: Treatment and control groups will be compared using pre- and post-tests measures. Post-tests will be at the conclusion of the intervention and at a 6, 12, and 18-month follow-ups. Process (e.g., parent satisfaction, compliance, etc) and outcome (e.g., behavior, family functioning, etc) measures will be evaluated.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date June 2005
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 3 Years to 7 Years
Eligibility Inclusion Criteria:

- Children ages 3 to 7 years

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind


Intervention

Behavioral:
Parent-child Interaction Therapy (PCIT)


Locations

Country Name City State
United States University of Oklahoma Health Sciences Center Oklahoma City Oklahoma

Sponsors (2)

Lead Sponsor Collaborator
Centers for Disease Control and Prevention University of Oklahoma

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary compliance with directives
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Active, not recruiting NCT00996528 - Neighborhood Alcohol & HIV Prevention in South African Townships (Philani) Phase 3
Completed NCT00164229 - Fetal Alcohol Syndrome: Socio-Cognitive Habilitation Phase 1/Phase 2
Recruiting NCT05534568 - The Oklahoma Parent-Child Assistance Program N/A
Recruiting NCT05385328 - Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Terminated NCT00747630 - Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS) Phase 0
Recruiting NCT04332172 - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy N/A
Completed NCT00696085 - Fetal Alcohol Damage Prevention Study N/A
Recruiting NCT00418262 - Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD Phase 3
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2
Recruiting NCT03371641 - In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions N/A
Completed NCT00164346 - Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND) Phase 1/Phase 2
Completed NCT01994603 - Expansion to Interdisciplinary HIV Prevention in Women N/A
Completed NCT00417794 - Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD Phase 1
Completed NCT02600624 - Prenatal Alcohol Biomarker Study in Uruguay
Completed NCT00244062 - Healthy Moms Alcohol Intervention N/A
Recruiting NCT04395196 - RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure Phase 2